# Comprehensive Analysis of the Placenta–Cortex Transcriptomic Database Reveals a Neuroactive Ligand–Receptor Dysregulation After Prenatal Alcohol Exposure

**Authors:** Camille Sautreuil, Maryline Lecointre, Céline Derambure, Carole Brasse-Lagnel, Gaël Nicolas, Sophie Gil, Daniel D. Savage, Stéphane Marret, Florent Marguet, Bruno J. Gonzalez, Anthony Falluel-Morel

PMC · DOI: 10.3390/ijms27041819 · International Journal of Molecular Sciences · 2026-02-14

## TL;DR

Prenatal alcohol exposure disrupts gene communication between the placenta and fetal brain, potentially causing neurodevelopmental issues.

## Contribution

First comprehensive transcriptomic analysis of placenta–cortex gene expression changes due to prenatal alcohol exposure.

## Key findings

- PAE alters placenta–cortex gene expression profiles, affecting cell communication.
- 38 neuroactive ligands and receptors, including PACAP and angiotensinogen, are dysregulated.
- Sex-dependent expression patterns of PACAP receptors were confirmed via Western blot.

## Abstract

Neuroplacentology is an emerging field of research supporting that the placenta actively contributes to the fetal brain development through the release of bioactive molecules. Recent angiogenesis-focused data showed that prenatal alcohol exposure (PAE) disrupts inter-organ gene expression between the placenta and fetal cortex. The present study aimed to perform the first comprehensive and untargeted analysis of a murine placenta–cortex transcriptomic database of PAE. Gene lists from a recently NCBI-deposited PAE Placenta–Cortex transcriptomic database were analyzed using g:Profiler for unbiased functional profiling querying Gene Ontology, KEGG, and Reactome databases. Genes intersecting with cell–cell communication terms were submitted to STRING and ShinyGO analyses to identify enriched protein–protein interactions and pathways. Several ligand or receptor candidates were then validated by Western blot. g:Profiler revealed 21 enriched GO functional maps, seven KEGG pathways, and six Reactome pathways, of which 11 were related to cell-to-cell communication. STRING analysis exhibited substantial protein–protein interaction enrichments supporting that proteins belonging to the functional maps and pathways are biologically connected. Notably, 38 ligands or receptors from endocrine families including angiotensinogen, leptin, somatostatin, or PACAP were identified. Western blot analysis of protein candidates showed different validation patterns. In particular, the PACAP receptor family confirmed transcriptomic findings and revealed sex-dependent PAE-impacted expression profiles. The present study indicates that PAE is associated with alterations in the transcriptomic placenta–cortex expression profile, including changes in the expression ratios of several ligands and/or receptors implicated in key physiological pathways such as energy balance, vascular development, and neurogenesis. These transcriptomic associations suggest that altered placenta–fetal brain signaling at the gene expression level may be involved in alcohol-induced neurodevelopmental disorders, highlighting the need for future functional validation studies.

## Linked entities

- **Proteins:** lepa (leptin a), ADCYAP1 (adenylate cyclase activating polypeptide 1)

## Full-text entities

- **Genes:** ADCYAP1 (adenylate cyclase activating polypeptide 1) [NCBI Gene 116] {aka PACAP}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, VN1R17P (vomeronasal 1 receptor 17 pseudogene) [NCBI Gene 441931] {aka GPCR}, VIPR1 (vasoactive intestinal peptide receptor 1) [NCBI Gene 7433] {aka HVR1, II, PACAP-R-2, PACAP-R2, RDC1, V1RG}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, Pgf (placental growth factor) [NCBI Gene 18654] {aka PIGF, Plgf}, Vipr2 (vasoactive intestinal peptide receptor 2) [NCBI Gene 22355] {aka VPAC2, VPAC2R, Vip2}, Adcyap1r1 (adenylate cyclase activating polypeptide 1 receptor 1) [NCBI Gene 11517] {aka 2900024I10Rik, PAC1, PAC1R, PACAP1-R}, Igf1 (insulin-like growth factor 1) [NCBI Gene 16000] {aka C730016P09Rik, Igf-1, Igf-I}, Sst (somatostatin) [NCBI Gene 20604] {aka SOM, SRIF, SS, Smst}, AGT (angiotensinogen) [NCBI Gene 183] {aka ANHU, SERPINA8, hFLT1}, FAS (Fas cell surface death receptor) [NCBI Gene 355] {aka ALPS1A, APO-1, APT1, CD95, FAS1, FASTM}, SST (somatostatin) [NCBI Gene 6750] {aka SMST, SST1}, SSTR2 (somatostatin receptor 2) [NCBI Gene 6752] {aka SST2}, Grp (gastrin releasing peptide) [NCBI Gene 225642] {aka BLP}, Lep (leptin) [NCBI Gene 16846] {aka ob, obese}, VIP (vasoactive intestinal peptide) [NCBI Gene 7432] {aka PHM27}, Flt1 (FMS-like tyrosine kinase 1) [NCBI Gene 14254] {aka Flt-1, VEGFR-1, VEGFR1, sFlt1}, Adcyap1 (adenylate cyclase activating polypeptide 1) [NCBI Gene 11516] {aka PACAP}, Grin1 (glutamate receptor, ionotropic, NMDA1 (zeta 1)) [NCBI Gene 14810] {aka GluN1, GluRdelta1, GluRzeta1, M100174, NMD-R1, NMDAR1}, Mcam (melanoma cell adhesion molecule) [NCBI Gene 84004] {aka 1-gicerin, CD146, CD149, Muc18, s-endo, s-gicerin}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, Agt (angiotensinogen) [NCBI Gene 11606] {aka AngI, AngII, Aogen, Serpina8}, PGF (placental growth factor) [NCBI Gene 5228] {aka D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760}, Vipr1 (vasoactive intestinal peptide receptor 1) [NCBI Gene 22354] {aka VIP-R1, VPAC1}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, ADCYAP1R1 (ADCYAP receptor type I) [NCBI Gene 117] {aka PAC1, PAC1R, PACAPR, PACAPRI}
- **Diseases:** Arrhythmogenic right ventricular cardiomyopathy (MESH:D019571), neurodevelopmental pathologies (MESH:D005598), neurodevelopmental disorders (MESH:D002658), sex dysmorphism (MESH:D058533), neurodevelopmental impairments (MESH:D009422), neurodevelopmental troubles (MESH:D008607), placenta-cortex dysfunction (MESH:D010922), Dilated cardiomyopathy (MESH:D002311), vascular defects (MESH:D057772), neurobehavioral troubles (MESH:D019954), cardiomyopathies (MESH:D009202), vascular dysregulation (MESH:D021081), injury to (MESH:D014947), cranio-facial dysmorphisms (MESH:C537339), autism spectrum disorder (MESH:D000067877), PAE (MESH:D011297), dysmorphisms (MESH:D057215), FASD (MESH:D063647)
- **Chemicals:** steroids (MESH:D013256), ATP (MESH:D000255), Alcohol (MESH:D000438), PVDF (MESH:C024865), Tween 20 (MESH:D011136), PAE (-), glycerol (MESH:D005990), amino acid (MESH:D000596), TBS (MESH:D013725), acetylcholine (MESH:D000109), HCl (MESH:D006851), glutamate (MESH:D018698), progesterone (MESH:D011374), SDS (MESH:D012967), Laemmli buffer (MESH:C088816), ethanol (MESH:D000431), NaCl (MESH:D012965), Metal (MESH:D008670), oxygen (MESH:D010100), bromophenol blue (MESH:D001978), polyacrylamide (MESH:C016679)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** G2519F

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940763/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940763/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940763/full.md

---
Source: https://tomesphere.com/paper/PMC12940763